Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Surgery
>
2022
>
60
>
4
Volume:
60
Issue:
4
1. Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022).
Page:310—320
2. Expert consensus on clinical application of multi-chamber bag for parenteral nutrition (2022).
Page:321—328
3. Chinese multidisciplinary collaborative expert consensus for the diagnosis and treatment of Budd-Chiari syndrome (2021 version).
Page:329—336
4. Interpretation of consensus on the surgical management of benign gallbladder diseases (2021 edition).
Page:337—342
5. Significance of combination of targeted therapy and immunotherapy in conversion therapy of biliary tract cancer.
Page:343—350
6. Thinking and suggestion on the definition, classification and Chinese nomenclature of carcinoma of the bile ducts.
Page:351—355
7. Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection.
Page:356—362
8. A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
Page:363—371
9. Application of enhanced recovery after surgery in perioperative management of patients with gallbladder carcinoma.
Page:372—377
10. The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery.
Page:378—386
11. Progress in diagnosis and treatment of gangrenous cholecystitis.
Page:391—395
12. Review of risk evaluation scores for benign end stage liver diseases recipients.
Page:397—401
13. Review of risk evaluation scores for benign end stage liver diseases recipients.
Page:396—400
